Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q9NRX4
UPID:
PHP14_HUMAN
Alternative names:
Phosphohistidine phosphatase 1; Protein histidine phosphatase; Protein janus-A homolog
Alternative UPACC:
Q9NRX4; B1AMX0; B1AMX1; Q9H0Y3
Background:
The 14 kDa phosphohistidine phosphatase, also known as Phosphohistidine phosphatase 1, Protein histidine phosphatase, and Protein janus-A homolog, plays a crucial role in cellular processes through its phosphohistidine phosphatase activity. This enzyme is pivotal in the regulation of phosphorylation, a key post-translational modification affecting numerous cellular pathways.
Therapeutic significance:
Understanding the role of 14 kDa phosphohistidine phosphatase could open doors to potential therapeutic strategies. Its unique enzymatic activity suggests a significant, yet untapped, potential in drug discovery, particularly in diseases where phosphorylation plays a critical role.